Ginkgo bilobaExtract for Patients with Early Diabetic Nephropathy: A Systematic Review

Abstract

Objectives. To evaluate the effectiveness and safety of a Ginkgo biloba extract for patients with early diabetic nephropathy. Methods. Randomised controlled trials (RCTs) conducted on adults with early diabetic nephropathy which used Gingko biloba extract were included. The major databases were searched, and manufacturers of Gingko biloba products were contacted for information on any published or unpublished studies. Two authors independently extracted the data from the included studies. Data analysis was conducted using Review Manager 5.0 software. Results. Sixteen RCTs were included. Ginkgo biloba extract decreased the urinary albumin excretion rate (UAER), fasting blood glucose (FBG), serum creatinine (SCR), and blood urea nitrogen (BUN). The extract also improved hemorheology. The methodological quality in the included studies was low. The explicit generation of the allocation sequence was described in only 6 trials. None of the included trials were confirmed to use blinding. Three studies had observed adverse events. One study using angiotensin-converting enzyme inhibitor (ACEi) reported mild cough in both groups. No serious adverse effects were reported. Conclusions. Gingko biloba extract is a valuable drug which has prospect in treating early diabetic nephropathy, especially with high UAER baseline level. The safety for early diabetic nephropathy is uncertain. Long-term, double-blinded RCTs with large sample sizes are still needed to provide stronger evidence.

Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats

“…The most common way to establish an animal model of diabetic nephropathy is by using streptozotocin (STZ) [15], which is characterized by high efficiency, simplicity, and stability. STZ can induce pancreatic cell apoptosis, Type 1 diabetes, diabetic nephropathy, as well as cause the proliferation of glomerular endothelial cells [16]. In this study, SD rats were given an intraperitoneal injection of streptozotocin (45 mg kg -1 ); three days after the injection, a significant increase in blood glucose, feed and water intake, and urine volume was noted.…”

Efficacy and safety of Ginkgo biloba for patients with early diabetic nephropathy

“…A previous article has systematically reviewed and confirmed the efficacy and safety of G biloba for early DN. [ 34 ] However, due to the deficiency of the methodological quality of the included studies, there is still a lack of strong clinical evidence. In addition, a number of new clinical trials have been carried out in recent years, especially in China.…”

A study on the recent 20 years’ herbal medication rules and syndromes distribution in TCM treatment of Diabetic Nephropathy by Data mining

“…Traditional Chinese medicine (TCM) has been widely used in the treatment of diabetes and its complications for a long time. [9][10][11] Up to now, there have been many experiments focusing on the treatment of diabetes and its complications with traditional Chinese medicine (TCM) because of less toxicity and/or side effects. 12,13 From ancient times to the present, diabetic nephropathy has many diseases name in TCM, and it is equivalent to the category of "urine turbidity", "edema", "kidney fatigue", "Guan-ge" and "kidney-elimination" in TCM.…”